Advanced search
Publication Cover
Gynecological Endocrinology Volume 36, 2020 - Issue 2
Submit an article Journal homepage
400
Views
18
CrossRef citations to date
0
Altmetric
Intralipid Therapy and Pregnancy Outcome in Recurrent Implantation Failure After ICSI

Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial

Jawharah Al-ZebeidiReproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia;
,
Mohammed AgdiReproductive Medicine, Bnoon Medical Center, Riyadh, Saudi Arabia
,
Sahar LaryReproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia;
,
Solaiman Al-ObaidReproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia;
,
Gamar SalimReproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia;
&
Dania Al-JaroudiReproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia; Correspondence[email protected] [email protected]
Pages 131-134 | Received 06 Mar 2019, Accepted 10 Jun 2019, Published online: 21 Jun 2019

References

  • Navot D, Bergh PA, Williams M, et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab. 1991;72:408–414.
  • Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet. 2012;29:1227–1239.
  • Chaouat G, Dubanchet S, Ledee N. Cytokines: important for implantation? J Assist Reprod Genet. 2007;24:491–505.
  • Sharkey A. Cytokines and implantation. Rev Reprod. 1998;3:52–61.
  • Sher G, Herbert C, Maassarani G, et al. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod. 1991;6:232–237.
  • de Mouzon J, Lancaster P, Nygren KG, et al. World collaborative report on assisted reproductive technology, 2002. Hum Reprod. 2009;24:2310–2320.
  • Ndukwe G. Recurrent embryo implantation failure after in vitro fertilisation: improved outcome following intralipid infusion in women with elevated T Helper 1 response. Hum Fertil. 2011;14:21–22.
  • Roussev RG, Acacio B, Ng SC, et al. ORIGINAL ARTICLE: duration of intralipid’s suppressive effect on NK cell’s functional activity. Am J Reprod Immunol. 2008;60:258–263.
  • Lainas TG, Sfontouris IA, Zorzovilis IZ, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Hum Reprod. 2010;25:683–689.
  • Kalfarentzos F, Kokkinis K, Leukaditi K, et al. Comparison between two fat emulsions: intralipid 30 cent vs intralipid 10 cent in critically ill patients. Clin Nutr. 1998;17:31–34.
  • Clark DA. Intralipid as treatment for recurrent unexplained abortion? Am J Reprod Immunol. 1994;32:290–293.
  • El-Khayat W, El Sadek M. Intralipid for repeated implantation failure (RIF): a randomized controlled trial. Fertil Steril. 2015;104:e26.
  • Al-Zebeidi J, Sahar Lary S, Al-Jaroudi D. The effect of fat emulsion intralipid 20% in reproductive outcome for patients with multiple implantation failure. Int J Women’s Health Reprod Sci. 2017;6:144–149.
  • Abdolmohammadi-Vahid S, Danaii S, Hamdi K, et al. Novel immunotherapeutic approaches for treatment of infertility. Biomed Pharmacother. 2016;84:1449–1459.
  • Check JH, Check DL. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40–42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer. Clin Exp Obstet Gynecol. 2016;43:14–15.
  • Dakhly DM, Bayoumi YA, Sharkawy M, et al. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells. Int J Gynaecol Obstet. 2016;135:324–327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.